All Type of News
Ildong Pharmaceutical signs ‘Fambir’ license agreement with Novartis
Ildong Pharmaceutical(CEO Woong-Sup Yoon) announced on the 25th that the company secured the Korean license of ‘Famvir(generic name: famciclovir),’ a Novartis’ viral herpes treatment, and has started to take marketing...
Daewoong Pharmaceutical’s ‘Anplone SR Tab’ wipes the market only in 3 years
Daewoong Pharmaceutical’s ‘Anplone SR Tab’ has become the leading product in the sarpogrelate release-type drug market in 3 years of its launch.
According to Daewoong Pharmaceutical, Anplone SR Tab was ranked the top...
MFDS decides to take contract manufacturing services for 3 products on Korean pharmas
The Ministry of Food and Drug Safety(MFDS) has a plan to enlarge the amount of national essential medicines to safely supply in Korea by signing more manufacturing contracts with pharmaceutical companies.
In order to...
Handok signs sales agreement of ‘Cialis in Korea with Lilly Korea
Handok(Chairman Young-Jin Kim) signed a strategic partnership agreement of selling ‘Cialis® Tab(generic name: tadalafil),’ a erectile dysfunction and positive benign prostatic hyperplasia treatment, in Korea with Lill...
Samsung Bioepis’ ‘Benepali’ & ‘Flixabi’ showing significant sales growths
Biogen, a European seller of Samsung Bioepis’ ‘Benepali’ and ‘Flixabi,’ has announced their performance(4th quarter performance in Europe) on the 25th(local time).
According to the performance, ‘Benepali(Enbrel biosi...
MSD CEO Avi BenShoshan appointed as new KRPIA President
The Korea Research-based Pharma Industry Association(KRPIA), on the 24th, announced to appoint Korea MSD CEO Avi BenShoshan as the 13th president to lead the association from February 2018.
New President Avi BenShosh...
‘Acetaminophen’ would not be used as ‘anti-inflammatory agent’
In order to prevent mis/abuse of medicines, the government will entirely revise the current therapeutic category system.
As one of this year’s tasks, the Ministry of Food and Drug Safety(MFDS) announced to address th...
Daewoong Pharmaceutical, “It was not a criticism about serious errors related to Nabota”
In regards to the news about the FDA’s onsite inspection for ‘Nabora,’ Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced on the 24th “The Daewoong Pharmaceutical’s Form 483 revealed at the FDA’s website is a docume...
Government reflects conditions about ‘Rebate market’ to respond to drugs confusing distribution order
The Ministry of Health and Welfare will revise the operational guideline so that price of drugs confusing distribution order will not drop in the rebate market.
The Ministry of Health and Welfare(Minister Neung-Hoo P...
Government will carry out tightening support standards for international symposiums in accordance with the draft
It seems the Anti-Corruption & Civil Rights Commission(ACRC) would carry out the ‘Proposal of Recommendation on Revision of Rebate Custom in the Health Care Field,’ which contains articles about the tightened support ...
